Please login to the form below
biopharma
This page shows the latest biopharma news and features for those working in and with pharma, biotech and healthcare.
BMS pays Zenas $50m upfront for regional rights to autoimmune disease antibody
Bristol Myers Squibb (BMS) and Zenas BioPharma have entered into a strategic license and collaboration agreement to develop and commercialise a novel, bi-functional antibody called obexelimab for autoimmune diseases.
Latest news
-
LEO Pharma to acquire Timber Pharmaceuticals in deal worth up to $36m
LEO Pharma has entered into a definitive agreement to acquire US biopharma company Timber Pharmaceuticals in a deal worth up to $36m.
-
Merck and Ginkgo Bioworks enter biologic manufacturing collaboration worth up to $490m
coli, and those that do express in E. coli may have better homologs that only express in fungal strains,” explained Behzad Mahdavi, the company’s senior vice president of biopharma manufacturing
-
Gilead expands IT partnership with Cognizant in deal worth approximately $800m
The partnership will see Cognizant manage Gilead's global IT infrastructure, platforms, applications and advanced analytics, and take charge of initiatives designed to accelerate the US biopharma's "digital transformation".
-
Alliance for Genomic Discovery announces its five founding biopharma members
The AGD aims to accelerate drug development and expand the diversity of genomic data
-
Pfizer and Flagship Pioneering sign drug discovery partnership worth up to $7bn
Pfizer has signed a deal with Flagship Pioneering worth up to $7bn to develop new drug candidates using the venture firm’s large portfolio of biopharma companies.
More from news
Approximately 26 fully matching, plus 499 partially matching documents found.
Latest Intelligence
-
The rise of biologics: is the sector ready for future demand?
Looking at the evolving biological sector and the various capacity challenges that global biopharma companies will have to bridge. ... For global biopharma companies, production capacity issues translate to a degree of uncertainty in balancing demand and
-
Maintaining continuity of care in Ukraine as conflict continues
Honouring the biopharma sector’s historical exemption from economic sanctions and an obligation to deliver life-saving medicines, regardless of circumstances, Pfizer announced that it would donate the equivalent of all
-
FlyPharma Europe unites pharma, biotech and bio pharma with air cargo logistics
The FlyPharma Conference Europe is a two-day event that brings together pharma, biopharma and biotech companies with air cargo and logistics services to promote open dialogue and solution- finding between ... Managing medicine shortages. Temperature
-
Product launches: making the most of your one shot
All biopharma companies recognise the vital importance of the launch to a product’s success. ... Launch execution platforms like SmartLaunch allow biopharma companies to apply the same rigor and failsafe approach to launch execution as they already do
-
The new reality of building a corporate brand in pharma
According to a 2019/20 Deloitte survey, 68% of biopharma leaders said that advances in technology are one of the top five issues that will have the most impact on their
More from intelligence
Approximately 1 fully matching, plus 91 partially matching documents found.
Latest appointments
-
Inizio appoints Stefanie Christmas as global head of DE&I
team. “During my time with the company, I’ve worked with some phenomenal companies across the biotech, biopharma and pharmaceutical sectors.
-
Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
Arnhofer joins the agency with two decades of experience in the biopharma industry, having held a variety of senior positions at Merck &Co, Bayer AG and BioNTech SE.
-
CureVac taps Klaus Edvardsen for chief development officer role
Edvardsen joins the German biopharma company from Merck KGaA. German biopharma company CureVac has appointed Klaus Edvardsen (pictured above) as its new chief development officer.
-
New hires at Crescendo, Healx and Galecto
Prior to joining Healx, he worked as CMO at Aparito and as therapeutic area head of orphan drugs at Mereo BioPharma.
-
New hires at FibroGen, Saniona and Turbine
Jenkins is a biopharma thought leader with over 25 years of industry experience, whose leadership roles have included global head of R&D at Merck Serono, and several senior positions at
More from appointments
Approximately 8 fully matching, plus 145 partially matching documents found.
Latest from PMHub
-
Pharma conference trends and themes in the last two years
Digital innovation – Conferences have seen an ongoing focus on digital transformation in the health sector as more biopharma companies look to increase investment in digital developments to improve the patient journey.
-
Mtech Access
Our areas of expertise include:. Our clients include top-20 Pharmaceutical and Medical Device companies, as well as smaller specialist biopharma and medtech companies.
-
Going beyond the buzzword: omnichannel and healthcare marketing
The state of omnichannel in biopharma 2022 global trends report.
-
Diversifying Healthcare AI with Federated Learning
He will also explore how to create equitable access to advanced AI-based diagnostics and treatment pathways, how biopharma companies can leverage federated learning to overcome the challenges of accessing
-
SCIRIS ACQUIRES SOURCE HEALTH ECONOMICS
Its client list includes many leading pharmaceutical, biopharma and diagnostic companies.
More from PMHub
Approximately 7 fully matching, plus 41 partially matching documents found.
Subscribe to our email news alerts
- COVID-19 could be key in identifying viruses with pandemic potential
- Novo Nordisk Foundation commits €127m for new cell therapy facility
- Alzheimer’s Research UK launches ‘Change The Ending’ campaign
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
No results were found
PMHub
Oxford University Press
Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
